In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Associate Professor Davide Capodanno
Speaker
Associate Professor Davide Capodanno
Davide Capodanno Davide Capodanno

University of Catania, Catania (Italy)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Pharmacology and Pharmacotherapy

Davide Capodanno, MD, PhD, is Associate Professor of Cardiology at the University of Catania and Interventional Cardiologist at the Azienda “Policlinico-Vittorio Emanuele” in Catania, Italy. He has authored more than 400 manuscripts, 4 textbooks of interventional cardiology and 11 textbook chapters, and he has delivered about 150 invited lectures in international meetings. Prof. Capodanno is the Chair of the Scientific Documents and Initiatives Committee of the EAPCI. He is Co-Director of the PCR Clinical Research Course and Associate Director of TCT. He is a member of the Working Group on Thrombosis of the ESC and a member of the Educative Solutions Research Group Programme of PCR. Prof. Capodanno serves as Editor-in-Chief of Eurointervention, Associate Editor of the European Heart Journal, Section Editor of Thrombosis and Haemostasis and Editorial Consultant of JACC Cardiovascular Interventions.

19 presentations from this speaker

Acute coronary syndromes.

Event : ESC Congress 2019

  • Session : ESC Congress Highlights
  • Speaker : D Capodanno (Catania,IT)

Case 2: best antithrombotic cocktail for patients with and without atrial fibrillation undergoing TAVI.

Event : ESC Congress 2019

  • Session : Meet the Experts - Clinical challenges while dealing with antithrombotic therapy
  • Speaker : D Capodanno (Catania,IT)

Long-term TAVI durability - What do we know so far?

Event : ESC Congress 2019

  • Session : Aortic stenosis treatment evolution – Which therapy for which patient?
  • Speaker : D Capodanno (Catania,IT)
  • Sponsored by Medtronic

Patients with longstanding diagnosis of coronary artery disease.

Event : ESC Congress 2019

  • Session : 2019 ESC Guidelines on Chronic Coronary Syndromes
  • Speaker : D Capodanno (Catania,IT)

Triple therapy post PCI in patients with atrial fibrillation: What do current trial data say / What do the guidelines tell us?

Event : Webinar 2019

  • Session : EHRA Webinars 2019
  • Speaker : D Capodanno (Catania,IT), H Heidbuchel (Antwerp,BE), M Hemels (Arnhem,NL)

What do the new Chronic Coronary Syndromes Guidelines suggest?

Event : ESC Congress 2019

  • Session : Novel ESC Guidelines 2019 – Clinical cases put into practice
  • Speaker : D Capodanno (Catania,IT)

Acute coronary syndromes.

Event : ESC Congress 2018

  • Session : ESC Congress Highlights
  • Speaker : D Capodanno (Catania,IT)

Durability of transcatheter heart valves - Worse, similar, or better than surgical valves?

Event : ESC Congress 2018

  • Session : Live in the Box: TAVI beyond the tricuspid high-risk elderly
  • Speaker : D Capodanno (Catania,IT)

Predictors of TAVI prosthesis degeneration

Event : ESC Congress 2018

  • Session : A look from the other side: the pathology of complications following transcatheter intervention
  • Speaker : D Capodanno (Catania,IT)
  • Joint with the Association for European Cardiovascular Pathology

Discussion - Optimising antiplatelet therapy from first medical contact to discharge.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - The patient journey after an acute coronary syndrome - A clinical case study.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - Who, when and why - The rationale to treat beyond 12 months.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Welcome and introduction - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Bioabsorbable stents.

Event : ESC Congress 2014

  • Session : Recent advances in Cardiology: what does the busy cardiologist need to know about…
  • Speaker : D Capodanno (Catania,IT)

Managing TAVI.

Event : ESC Congress 2014

  • Session : Warfarin or new anticoagulants in atrial fibrillation patients undergoing PCI
  • Speaker : D Capodanno (Catania,IT)

"Bridging therapy" with low molecular weight heparin in patients with coronary stents undergoing surgery

Event : ESC Congress 2013

  • Session : Antithrombotics and intervention in acute coronary syndromes
  • Speaker : D Capodanno (Catania,IT)

Dual antiplatelet therapy to the elderly?

Event : ESC Congress 2013

  • Session : Controversal issues in acute coronary syndrome management
  • Speaker : D Capodanno (Catania,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are